University College London Hospitals NHS Foundation Trust
Regione Toscana
MedDay Pharmaceuticals
EMD Serono
Medical Research Council
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article
Blood biomarker dynamics in people with relapsing multiple sclerosis treated with cladribine tablets: results of the 2-year MAGNIFY-MS study
Finn Thorup Sellebjerg, Anita Chudecka, Andreas Kloetgen, Nicola De Stefano et al.
Citations
9 citations
Journal
Frontiers in Immunology
Topics
Multiple Sclerosis Research Studies
Field-Weighted Citation Impact (FWCI)
13.24
article
Blood biomarker dynamics in people with relapsing multiple sclerosis treated with cladribine tablets: results of the 2-year MAGNIFY-MS study
Finn Thorup Sellebjerg, Anita Chudecka, Andreas Kloetgen, Nicola De Stefano, Patrick Vermersch, Xavier Montalbán, Letizia Leocani, Klaus Schmierer, Suzanne Hodgkinson, Lidia A. Gardner, Frederik Barkhof, Andrew T. Chan, Tobias J Derfuss, Alexandre Prat, Anat Achiron, Dongdong Lin, Heinz Wiendl, Hulin Jin
article en
9 citations
Abstract
No abstract available for this paper.
Publication Tag
Frontiers in ImmunologyVol. 16
Institutions
University of Siena (IT), University of Bern (CH), University of Copenhagen (DK), Vita-Salute San Raffaele University (IT), Inserm (FR), Tel Aviv University (IL), Merck KGaA, Darmstadt (Germany) (DE), Queen Mary University of London (GB), University of Münster (DE), Barts Health NHS Trust (GB), Université de Lille (FR), Sheba Medical Center (IL), Liverpool Hospital (AU), University Hospital of Bern (CH), Royal London Hospital (GB), University Hospital of Basel (CH), Copenhagen University Hospital (DK), Rigshospitalet (DK), Centre Hospitalier Universitaire de Lille (FR), UNSW Sydney (AU), Ono Pharmaceutical (United States) (US), Casa di Cura Columbus (IT), Research & Development Institute (US), Ingham Institute (AU), National Hospital for Neurology and Neurosurgery (GB), Amsterdam University Medical Centers (NL), Istituti di Ricovero e Cura a Carattere Scientifico (IT), Centre d'Esclerosi Múltiple de Catalunya (ES), University College London (GB), Université de Montréal (CA), Vrije Universiteit Amsterdam (NL), Cytel (United States) (US)
Funders
Bristol-Myers Squibb, Sanofi, Biogen, Teva Pharmaceutical Industries, Alexion Pharmaceuticals, Celgene, CSL Behring, McGill University, Merck KGaA, McGill University Health Centre, Prothena, Fresenius Medical Care North America, University of Alberta, National Institute for Health and Care Research, European Commission, Deutsche Forschungsgemeinschaft, Bundesministerium für Bildung und Forschung, Technische Universität Dresden, Westfälische Wilhelms-Universität Münster, Rheinische Friedrich-Wilhelms-Universität Bonn, University College London Hospitals NHS Foundation Trust, Regione Toscana, MedDay Pharmaceuticals, EMD Serono, Medical Research Council